Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
Study NCT ID:
NCT02177812
Status:
TERMINATED
Last Update Posted:
2019-06-28
First Post:
2014-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-26
First Submit QC Date:
None
Study First Post Date:
2014-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-07
Results First Submit QC Date:
None
Results First Post Date:
2019-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-02
Last Update Post Date:
2019-06-28
Last Update Post Date Type:
ACTUAL